VHL-HIF-2α axis-induced SMYD3 upregulation drives renal cell carcinoma progression via direct trans-activation of the epidermal growth factor receptor gene

VHL-HIF-2α axis-induced SMYD3 upregulation drives renal cell carcinoma progression via direct trans-activation of the epidermal growth factor receptor gene

Bibliographic Details
Main Authors:	C. Liu, L. Liu, Y. Hao, F. Yang, L. Ma
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320335813

Similar Items

VHL-HIF-2α axis-induced SEMA6A upregulation stabilized β-catenin to drive clear cell renal cell carcinoma progression
by: Jing Ji, et al.
Published: (2023-02-01)

The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma
by: Song Peng, et al.
Published: (2020-11-01)

Downstream Targets of VHL/HIF-α Signaling in Renal Clear Cell Carcinoma Progression: Mechanisms and Therapeutic Relevance
by: Sonia Mazumder, et al.
Published: (2023-02-01)

Renal tubular HIF-2α expression requires VHL inactivation and causes fibrosis and cysts.
by: Ruth E Schietke, et al.
Published: (2012-01-01)

VHL-P138R and VHL-L163R Novel Variants: Mechanisms of VHL Pathogenicity Involving HIF-Dependent and HIF-Independent Actions
by: Cecilia Mathó, et al.
Published: (2022-03-01)

Effects of point mutations in pVHL on the binding of HIF-1α.
by: Domene, C, et al.
Published: (2012)

Effects of point mutations in pVHL on the binding of HIF-1α
by: Domene, C, et al.
Published: (2012)

The role of miRNA genes participating in VHL-HIF1α in clear cell renal cell carcinoma
by: V. N. Pavlov, et al.
Published: (2019-02-01)

Evolution of metazoan oxygen-sensing involved a conserved divergence of VHL affinity for HIF1α and HIF2α
by: Daniel Tarade, et al.
Published: (2019-07-01)

PI3K/AKT/mTOR Dysregulation and Reprogramming Metabolic Pathways in Renal Cancer: Crosstalk with the VHL/HIF Axis
by: Silviu Constantin Badoiu, et al.
Published: (2023-05-01)

Zafirlukast Induces VHL- and HIF-2α-Dependent Oxidative Cell Death in 786-O Clear Cell Renal Carcinoma Cells
by: Christopher Wolf, et al.
Published: (2022-03-01)

Inhibition of HIF2α Protein Suppresses pVHL-Driven Tumor Growth.
Published: (2003-12-01)

VHL-recruiting PROTAC attenuates renal fibrosis and preserves renal function via simultaneous degradation of Smad3 and stabilization of HIF-2α
by: Jiayi Yang, et al.
Published: (2022-12-01)

VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells
by: Xueyou Ma, et al.
Published: (2022-05-01)

Cholesterol accumulation in ccRCC: the role of ccRCC-initiating VHL-HIFα pathway
by: M. Aiman Mohtar, et al.
Published: (2024-05-01)

Up-regulation of pVHL along with down-regulation of HIF-1α by NDRG2 expression attenuates proliferation and invasion in renal cancer cells.
by: Lei Gao, et al.
Published: (2013-01-01)

Inhibition of VHL by VH298 Accelerates Pexophagy by Activation of HIF-1α in HeLa Cells
by: Yong Hwan Kim, et al.
Published: (2024-01-01)

Potent and selective chemical probe of hypoxic signalling downstream of HIF-α hydroxylation via VHL inhibition
by: Julianty Frost, et al.
Published: (2016-11-01)

VHL regulates the sensitivity of clear cell renal cell carcinoma to SIRT4-mediated metabolic stress via HIF-1α/HO-1 pathway
by: Ying Tong, et al.
Published: (2021-06-01)

UBE2S promotes malignant properties via VHL/HIF‐1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma
by: Junyi Wu, et al.
Published: (2023-09-01)

Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL.
by: Hon, W, et al.
Published: (2002)

CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma.
by: McRonald, F, et al.
Published: (2009)

Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma
by: Junhui Hu, et al.
Published: (2023-04-01)

Retraction. Up-regulation of pVHL along with down-regulation of HIF-1α by NDRG2 expression attenuates proliferation and invasion in renal cancer cells.
Published: (2014-01-01)

MDM2 promotes cancer cell survival through regulating the expression of HIF-1α and pVHL in retinoblastoma
by: Shouhua Zhang, et al.
Published: (2023-01-01)

Loss of Von Hippel–Lindau (<i>VHL</i>) Tumor Suppressor Gene Function: <i>VHL</i>–HIF Pathway and Advances in Treatments for Metastatic Renal Cell Carcinoma (RCC)
by: Hyunho Kim, et al.
Published: (2021-09-01)

The pVHL-hIF-1 system. A key mediator of oxygen homeostasis.
by: Maxwell, P, et al.
Published: (2001)

CpG methylation profiling in <it>VHL </it>related and <it>VHL </it>unrelated renal cell carcinoma
by: Clarke Noel W, et al.
Published: (2009-06-01)

HIF1α and HIF2α exert distinct nutrient preferences in renal cells.
by: Alexandra Arreola, et al.
Published: (2014-01-01)

OGT/HIF-2α axis promotes the progression of clear cell renal cell carcinoma and regulates its sensitivity to ferroptosis
by: Zhou Yang, et al.
Published: (2023-11-01)

VHL deficiency drives enhancer activation of oncogenes in clear cell renal cell carcinoma
by: Yao, X, et al.
Published: (2017)

NADH elevation during chronic hypoxia leads to VHL-mediated HIF-1α degradation via SIRT1 inhibition
by: Hyun-Yoo Joo, et al.
Published: (2023-09-01)

Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth.
by: Keiichi Kondo, et al.
Published: (2003-12-01)

Acute Vhl gene inactivation induces cardiac HIF-dependent erythropoietin gene expression.
by: Marta Miró-Murillo, et al.
Published: (2011-01-01)

Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.
by: Pollard, P, et al.
Published: (2006)

Expression of HIF-1a, HIF-2a (EPAS1), and their target genes in paraganglioma and phaeochromocytoma with VHL and SDH mutations
by: Pollard, P, et al.
Published: (2006)

SMYD2 aggravates gastrointestinal stromal tumor via upregulation of EZH2 and downregulation of TET1
by: Yong Ji, et al.
Published: (2022-06-01)

Tumor cells upregulate normoxic HIF-1α in response to doxorubicin
by: Cao, Y, et al.
Published: (2013)

SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis
by: Kangdi Xu, et al.
Published: (2022-12-01)

Proline-hydroxylated hypoxia-inducible factor 1α (HIF-1α) upregulation in human tumours.
by: Cameron E Snell, et al.
Published: (2014-01-01)